Fecal Calprotectin Test Market (Patient Type: Adult and Pediatric; Assay Type: ELISA, Enzyme Fluoroimmunoassay, and Quantitative Immune-chromatography) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

TMR's report on the global Fecal Calprotectin Test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Fecal Calprotectin Test market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Fecal Calprotectin Test market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Fecal Calprotectin Test market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Fecal Calprotectin Test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Fecal Calprotectin Test market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Fecal Calprotectin Test market.

The report delves into the competitive landscape of the global Fecal Calprotectin Test market. Key players operating in the global Fecal Calprotectin Test market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Fecal Calprotectin Test market profiled in this report.

Key Questions Answered in Global Fecal Calprotectin Test Market Report:

What is the sales/revenue generated by Fecal Calprotectin Test across all regions during the forecast period?
What are the opportunities in the global Fecal Calprotectin Test market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Fecal Calprotectin Test Market - Research Objectives and Research Approach

The comprehensive report on the global Fecal Calprotectin Test market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Fecal Calprotectin Test market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Fecal Calprotectin Test market.

Product Code: TMRGL78383

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Fecal Calprotectin Test Market

4. Market Overview

4.1. Introduction
- 4.1.1. Patient Type Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Fecal Calprotectin Test Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Technological Advancement
5.2. Diseases Epidemiology
5.3. Regulatory Scenario
5.4. Pricing Analysis
5.5. COVID-19 Impact Analysis

6. Global Fecal Calprotectin Test Market Analysis and Forecast, by Patient Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Patient Type, 2017-2031
- 6.3.1. Adult
- 6.3.2. Pediatric
6.4. Market Attractiveness Analysis, by Patient Type

7. Global Fecal Calprotectin Test Market Analysis and Forecast, by Assay Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Assay Type, 2017-2031
- 7.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 7.3.2. Enzyme Fluoroimmunoassay
- 7.3.3. Quantitative Immune-chromatography
7.4. Market Attractiveness Analysis, by Assay Type

8. Global Fecal Calprotectin Test Market Analysis and Forecast, by Indication

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Indication, 2017-2031
- 8.3.1. Inflammatory Bowel Disease
- 8.3.2. Colorectal Cancer
- 8.3.3. Celiac Disease
8.4. Market Attractiveness Analysis, by Indication

9. Global Fecal Calprotectin Test Market Analysis and Forecast, by End-user

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Diagnostic Laboratories
- 9.3.3. Academic & Research Institutes
9.4. Market Attractiveness Analysis, by End-user

10. Global Fecal Calprotectin Test Market Analysis and Forecast, by Region

10.1. Key Findings
10.2. Market Value Forecast, by Region
- 10.2.1. North America
- 10.2.2. Europe
- 10.2.3. Asia Pacific
- 10.2.4. Latin America
- 10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region

11. North America Fecal Calprotectin Test Market Analysis and Forecast

11.1. Introduction
- 11.1.1. Key Findings
11.2. Market Value Forecast, by Patient Type, 2017-2031
- 11.2.1. Adult
- 11.2.2. Pediatric
11.3. Market Value Forecast, by Assay Type, 2017-2031
- 11.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 11.3.2. Enzyme Fluoroimmunoassay
- 11.3.3. Quantitative Immune-chromatography
11.4. Market Value Forecast, by Indication, 2017-2031
- 11.4.1. Inflammatory Bowel Disease
- 11.4.2. Colorectal Cancer
- 11.4.3. Celiac Disease
11.5. Market Value Forecast, by End-user, 2017-2031
- 11.5.1. Hospitals
- 11.5.2. Diagnostic Laboratories
- 11.5.3. Academic & Research Institutes
11.6. Market Value Forecast, by Country, 2017-2031
- 11.6.1. U.S.
- 11.6.2. Canada
11.7. Market Attractiveness Analysis
- 11.7.1. By Patient Type
- 11.7.2. By Assay Type
- 11.7.3. By Indication
- 11.7.4. By End-user
- 11.7.5. By Country

12. Europe Fecal Calprotectin Test Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Patient Type, 2017-2031
- 12.2.1. Adult
- 12.2.2. Pediatric
12.3. Market Value Forecast, by Assay Type, 2017-2031
- 12.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 12.3.2. Enzyme Fluoroimmunoassay
- 12.3.3. Quantitative Immune-chromatography
12.4. Market Value Forecast, by Indication, 2017-2031
- 12.4.1. Inflammatory Bowel Disease
- 12.4.2. Colorectal Cancer
- 12.4.3. Celiac Disease
12.5. Market Value Forecast, by End-user, 2017-2031
- 12.5.1. Hospitals
- 12.5.2. Diagnostic Laboratories
- 12.5.3. Academic & Research Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.6.1. Germany
- 12.6.2. U.K.
- 12.6.3. France
- 12.6.4. Italy
- 12.6.5. Spain
- 12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
- 12.7.1. By Patient Type
- 12.7.2. By Assay Type
- 12.7.3. By Indication
- 12.7.4. By End-user
- 12.7.5. By Country/Sub-region

13. Asia Pacific Fecal Calprotectin Test Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Patient Type, 2017-2031
- 13.2.1. Adult
- 13.2.2. Pediatric
13.3. Market Value Forecast, by Assay Type, 2017-2031
- 13.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 13.3.2. Enzyme Fluoroimmunoassay
- 13.3.3. Quantitative Immune-chromatography
13.4. Market Value Forecast, by Indication, 2017-2031
- 13.4.1. Inflammatory Bowel Disease
- 13.4.2. Colorectal Cancer
- 13.4.3. Celiac Disease
13.5. Market Value Forecast, by End-user, 2017-2031
- 13.5.1. Hospitals
- 13.5.2. Diagnostic Laboratories
- 13.5.3. Academic & Research Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.6.1. China
- 13.6.2. Japan
- 13.6.3. India
- 13.6.4. Australia & New Zealand
- 13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
- 13.7.1. By Patient Type
- 13.7.2. By Assay Type
- 13.7.3. By Indication
- 13.7.4. By End-user
- 13.7.5. By Country/Sub-region

14. Latin America Fecal Calprotectin Test Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Patient Type, 2017-2031
- 14.2.1. Adult
- 14.2.2. Pediatric
14.3. Market Value Forecast, by Assay Type, 2017-2031
- 14.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 14.3.2. Enzyme Fluoroimmunoassay
- 14.3.3. Quantitative Immune-chromatography
14.4. Market Value Forecast, by Indication, 2017-2031
- 14.4.1. Inflammatory Bowel Disease
- 14.4.2. Colorectal Cancer
- 14.4.3. Celiac Disease
14.5. Market Value Forecast, by End-user, 2017-2031
- 14.5.1. Hospitals
- 14.5.2. Diagnostic Laboratories
- 14.5.3. Academic & Research Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.6.1. Brazil
- 14.6.2. Mexico
- 14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
- 14.7.1. By Patient Type
- 14.7.2. By Assay Type
- 14.7.3. By Indication
- 14.7.4. By End-user
- 14.7.5. By Country/Sub-region

15. Middle East & Africa Fecal Calprotectin Test Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Patient Type, 2017-2031
- 15.2.1. Adult
- 15.2.2. Pediatric
15.3. Market Value Forecast, by Assay Type, 2017-2031
- 15.3.1. ELISA (Enzyme linked Immunosorbent Assay)
- 15.3.2. Enzyme Fluoroimmunoassay
- 15.3.3. Quantitative Immune-chromatography
15.4. Market Value Forecast, by Indication, 2017-2031
- 15.4.1. Inflammatory Bowel Disease
- 15.4.2. Colorectal Cancer
- 15.4.3. Celiac Disease
15.5. Market Value Forecast, by End-user, 2017-2031
- 15.5.1. Hospitals
- 15.5.2. Diagnostic Laboratories
- 15.5.3. Academic & Research Institutes
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.6.1. GCC Countries
- 15.6.2. South Africa
- 15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
- 15.7.1. By Patient Type
- 15.7.2. By Assay Type
- 15.7.3. By Indication
- 15.7.4. By End-user
- 15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player - Competitive Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
- 16.3.1. Abbexa
  - 16.3.1.1. Company Overview
  - 16.3.1.2. Drug Class Portfolio
  - 16.3.1.3. SWOT Analysis
  - 16.3.1.4. Financial Overview
  - 16.3.1.5. Strategic Overview
- 16.3.2. ALPCO
  - 16.3.2.1. Company Overview
  - 16.3.2.2. Drug Class Portfolio
  - 16.3.2.3. SWOT Analysis
  - 16.3.2.4. Financial Overview
  - 16.3.2.5. Strategic Overview
- 16.3.3. Alpha Laboratories
  - 16.3.3.1. Company Overview
  - 16.3.3.2. Drug Class Portfolio
  - 16.3.3.3. SWOT Analysis
  - 16.3.3.4. Financial Overview
  - 16.3.3.5. Strategic Overview
- 16.3.4. Biomerica
  - 16.3.4.1. Company Overview
  - 16.3.4.2. Drug Class Portfolio
  - 16.3.4.3. SWOT Analysis
  - 16.3.4.4. Financial Overview
  - 16.3.4.5. Strategic Overview
- 16.3.5. BUHLMANN Laboratories AG
  - 16.3.5.1. Company Overview
  - 16.3.5.2. Drug Class Portfolio
  - 16.3.5.3. SWOT Analysis
  - 16.3.5.4. Financial Overview
  - 16.3.5.5. Strategic Overview
- 16.3.6. DRG Instruments GmbH
  - 16.3.6.1. Company Overview
  - 16.3.6.2. Drug Class Portfolio
  - 16.3.6.3. SWOT Analysis
  - 16.3.6.4. Financial Overview
  - 16.3.6.5. Strategic Overview
- 16.3.7. EagleBio
  - 16.3.7.1. Company Overview
  - 16.3.7.2. Drug Class Portfolio
  - 16.3.7.3. SWOT Analysis
  - 16.3.7.4. Financial Overview
  - 16.3.7.5. Strategic Overview
- 16.3.8. Epitope Diagnostics, Inc.
  - 16.3.8.1. Company Overview
  - 16.3.8.2. Drug Class Portfolio
  - 16.3.8.3. SWOT Analysis
  - 16.3.8.4. Financial Overview
  - 16.3.8.5. Strategic Overview
- 16.3.9. OPERON, S.A.
  - 16.3.9.1. Company Overview
  - 16.3.9.2. Drug Class Portfolio
  - 16.3.9.3. SWOT Analysis
  - 16.3.9.4. Financial Overview
  - 16.3.9.5. Strategic Overview
- 16.3.10. R-Biopharm AG
  - 16.3.10.1. Company Overview
  - 16.3.10.2. Drug Class Portfolio
  - 16.3.10.3. SWOT Analysis
  - 16.3.10.4. Financial Overview
  - 16.3.10.5. Strategic Overview
- 16.3.11. Svar Life Science
  - 16.3.11.1. Company Overview
  - 16.3.11.2. Drug Class Portfolio
  - 16.3.11.3. SWOT Analysis
  - 16.3.11.4. Financial Overview
  - 16.3.11.5. Strategic Overview
- 16.3.12. Thermo Fisher Scientific, Inc.
  - 16.3.12.1. Company Overview
  - 16.3.12.2. Drug Class Portfolio
  - 16.3.12.3. SWOT Analysis
  - 16.3.12.4. Financial Overview
  - 16.3.12.5. Strategic Overview
- 16.3.13. Werfen
  - 16.3.13.1. Company Overview
  - 16.3.13.2. Drug Class Portfolio
  - 16.3.13.3. SWOT Analysis
  - 16.3.13.4. Financial Overview
  - 16.3.13.5. Strategic Overview
- 16.3.14. SENTINEL CH. SpA
  - 16.3.14.1. Company Overview
  - 16.3.14.2. Drug Class Portfolio
  - 16.3.14.3. SWOT Analysis
  - 16.3.14.4. Financial Overview
  - 16.3.14.5. Strategic Overview
- 16.3.15. Diazyme Laboratories, Inc.
  - 16.3.15.1. Company Overview
  - 16.3.15.2. Drug Class Portfolio
  - 16.3.15.3. SWOT Analysis
  - 16.3.15.4. Financial Overview
  - 16.3.15.5. Strategic Overview
- 16.3.16. DiAgam
  - 16.3.16.1. Company Overview
  - 16.3.16.2. Drug Class Portfolio
  - 16.3.16.3. SWOT Analysis
  - 16.3.16.4. Financial Overview
  - 16.3.16.5. Strategic Overview

Product Code: TMRGL78383

List of Tables

Table 01: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
Table 02: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 03: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 04: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
Table 08: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 09: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 10: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
Table 13: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 14: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 15: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
Table 18: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 19: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 20: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Patient Type, 2017-2031
Table 23: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 24: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 25: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 28: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Assay Type, 2017-2031
Table 29: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by Indication, 2017-2031
Table 30: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Fecal Calprotectin Test Market Value Share, by Patient Type, 2022
Figure 03: Global Fecal Calprotectin Test Market Value Share, by Assay Type, 2022
Figure 04: Global Fecal Calprotectin Test Market Value Share, by Indication, 2022
Figure 05: Global Fecal Calprotectin Test Market Value Share, by End-user, 2022
Figure 06: Global Fecal Calprotectin Test Market Value Share, by Region, 2022
Figure 07: Global Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 08: Global Fecal Calprotectin Test Market (US$ Mn), by Adult, 2017-2031
Figure 09 Global Fecal Calprotectin Test Market (US$ Mn), by Pediatric, 2017-2031
Figure 10: Global Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 11: Global Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 12: Global Fecal Calprotectin Test Market (US$ Mn), by ELISA (Enzyme linked Immunosorbent Assay), 2017-2031
Figure 13 Global Fecal Calprotectin Test Market (US$ Mn), by Enzyme Fluoroimmunoassay, 2017-2031
Figure 14: Global Fecal Calprotectin Test Market (US$ Mn), by Quantitative Immune-chromatography, 2017-2031
Figure 15: Global Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 16: Global Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 17: Global Fecal Calprotectin Test Market (US$ Mn), by Inflammatory Bowel Disease, 2017-2031
Figure 18: Global Fecal Calprotectin Test Market (US$ Mn), by Colorectal Cancer, 2017-2031
Figure 19: Global Fecal Calprotectin Test Market (US$ Mn), by Celiac Disease, 2017-2031
Figure 20: Global Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 21: Global Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 22: Global Fecal Calprotectin Test Market (US$ Mn), by Hospitals, 2017-2031
Figure 23: Global Fecal Calprotectin Test Market (US$ Mn), by Diagnostic Laboratories, 2017-2031
Figure 24: Global Fecal Calprotectin Test Market (US$ Mn), by Academic & Research Institutes, 2017-2031
Figure 25: Global Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 26: Global Fecal Calprotectin Test Market Value Share Analysis, by Region, 2022 and 2031
Figure 27: Global Fecal Calprotectin Test Market Attractiveness Analysis, by Region, 2023-2031
Figure 28: North America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 29: North America Fecal Calprotectin Test Market Value Share Analysis, by Country, 2022 and 2031
Figure 30: North America Fecal Calprotectin Test Market Attractiveness Analysis, by Country, 2023-2031
Figure 31: North America Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 32: North America Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 33: North America Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 34: North America Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 35: North America Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 36: North America Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 37: North America Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: North America Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 39: Europe Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 40: Europe Fecal Calprotectin Test Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 41: Europe Fecal Calprotectin Test Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 42: Europe Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 43: Europe Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 44: Europe Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 45: Europe Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 46: Europe Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 47: Europe Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 48: Europe Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 49: Europe Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 50: Asia Pacific Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 51: Asia Pacific Fecal Calprotectin Test Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Asia Pacific Fecal Calprotectin Test Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Asia Pacific Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 54: Asia Pacific Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 55: Asia Pacific Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 56: Asia Pacific Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 57: Asia Pacific Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 58: Asia Pacific Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 51: Asia Pacific Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Asia Pacific Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 61: Latin America Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Latin America Fecal Calprotectin Test Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 63: Latin America Fecal Calprotectin Test Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 64: Latin America Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 65: Latin America Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 66: Latin America Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 67: Latin America Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 68: Latin America Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 69: Latin America Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 70: Latin America Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 71: Latin America Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 72: Middle East & Africa Fecal Calprotectin Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 73: Middle East & Africa Fecal Calprotectin Test Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 74: Middle East & Africa Fecal Calprotectin Test Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 75: Middle East & Africa Fecal Calprotectin Test Market Value Share Analysis, by Patient Type, 2022 and 2031
Figure 76: Middle East & Africa Fecal Calprotectin Test Market Attractiveness Analysis, by Patient Type, 2023-2031
Figure 77: Middle East & Africa Fecal Calprotectin Test Market Value Share Analysis, by Assay Type, 2022 and 2031
Figure 78: Middle East & Africa Fecal Calprotectin Test Market Attractiveness Analysis, by Assay Type, 2023-2031
Figure 79: Middle East & Africa Fecal Calprotectin Test Market Value Share Analysis, by Indication, 2022 and 2031
Figure 80: Middle East & Africa Fecal Calprotectin Test Market Attractiveness Analysis, by Indication, 2023-2031
Figure 81: Middle East & Africa Fecal Calprotectin Test Market Value Share Analysis, by End-user, 2022 and 2031
Figure 82: Middle East & Africa Fecal Calprotectin Test Market Attractiveness Analysis, by End-user, 2023-2031
Figure 83: Global Fecal Calprotectin Test Market Share, by Company, 2022

Fecal Calprotectin Test Market (Patient Type: Adult and Pediatric; Assay Type: ELISA, Enzyme Fluoroimmunoassay, and Quantitative Immune-chromatography) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Description

Table of Contents

List of Tables

Fecal Calprotectin Test Market - Scope of Report

Key Questions Answered in Global Fecal Calprotectin Test Market Report:

Fecal Calprotectin Test Market - Research Objectives and Research Approach

Table of Contents

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Fecal Calprotectin Test Market

4. Market Overview

5. Key Insights

6. Global Fecal Calprotectin Test Market Analysis and Forecast, by Patient Type

7. Global Fecal Calprotectin Test Market Analysis and Forecast, by Assay Type

8. Global Fecal Calprotectin Test Market Analysis and Forecast, by Indication

9. Global Fecal Calprotectin Test Market Analysis and Forecast, by End-user

10. Global Fecal Calprotectin Test Market Analysis and Forecast, by Region

11. North America Fecal Calprotectin Test Market Analysis and Forecast

12. Europe Fecal Calprotectin Test Market Analysis and Forecast

13. Asia Pacific Fecal Calprotectin Test Market Analysis and Forecast

14. Latin America Fecal Calprotectin Test Market Analysis and Forecast

15. Middle East & Africa Fecal Calprotectin Test Market Analysis and Forecast

16. Competition Landscape

List of Tables

List of Figures